Papadopoulou Soultana, Anagnostopouplou Areti, Katsarou Dimitra V, Megari Kalliopi, Efthymiou Efthymia, Argyriadis Alexandros, Kougioumtzis Georgios, Theodoratou Maria, Sofologi Maria, Argyriadi Agathi, Pavlidou Efterpi, Toki Eugenia I
Department of Speech Therapy, School of Health Sciences, University of Ioannina, 455 00 Ioannina, Greece.
Department of Preschool Education Sciences and Educational Design, University of the Aegean, 851 32 Rhodes, Greece.
Healthcare (Basel). 2024 Dec 30;13(1):52. doi: 10.3390/healthcare13010052.
This study presents a comprehensive investigation into the correlation between Rare Diseases and Syndromes (RDS) and the dysphagic disorders manifested during childhood and adulthood in affected patients. Dysphagia is characterized by difficulty or an inability to swallow food of any consistency, as well as saliva or medications, from the oral cavity to the stomach. RDS often present with complex and heterogeneous clinical manifestations, making it challenging to develop standardized diagnostic and therapeutic approaches. Dysphagia can arise from various etiologies, including those related to the central nervous system, inflammatory and neoplastic processes, anatomical or structural disorders, and neuromuscular conditions. These diverse etiologies can result in both structural and functional deficits or neurological impairments that compromise swallowing function. While RDS frequently leads to uncommon conditions, dysphagia remains an underrecognized complication. : The primary objective of this review is to illuminate the latest knowledge concerning the management of dysphagia in both pediatric and adult populations within the context of RDS, with a particular focus on current therapeutic approaches. To achieve this, the study provides a comprehensive analysis of existing strategies for managing dysphagia in RDS, highlighting recent advancements in therapy while identifying critical gaps in clinical knowledge and practice. By synthesizing available evidence, the review aims to deepen understanding of the unique challenges associated with dysphagia in these conditions and explore innovative interventions to enhance patient care and outcomes. The integration of innovative therapeutic techniques into the speech-language pathology treatment of dysphagia augments traditional strategies, offering updated knowledge that can be applied to prognosis and therapeutic interventions across various ages and racial groups. This review also provides an overview of symptomatology, assessment techniques, and the specific characteristics of dysphagia associated with various genetic and acquired RDS.
本研究全面调查了罕见病与综合征(RDS)与受影响患者在儿童期和成年期出现的吞咽障碍之间的相关性。吞咽困难的特征是难以或无法将任何稠度的食物、唾液或药物从口腔吞咽到胃中。RDS通常表现出复杂多样的临床表现,这使得制定标准化的诊断和治疗方法具有挑战性。吞咽困难可由多种病因引起,包括与中枢神经系统、炎症和肿瘤过程、解剖或结构紊乱以及神经肌肉疾病相关的病因。这些不同的病因可导致结构和功能缺陷或神经损伤,从而损害吞咽功能。虽然RDS经常导致罕见病症,但吞咽困难仍然是一种未被充分认识的并发症。本综述的主要目的是阐明在RDS背景下儿科和成人人群吞咽困难管理的最新知识,特别关注当前的治疗方法。为实现这一目标,该研究对RDS中吞咽困难的现有管理策略进行了全面分析,突出了治疗方面的最新进展,同时确定了临床知识和实践中的关键差距。通过综合现有证据,本综述旨在加深对这些病症中与吞咽困难相关的独特挑战的理解,并探索创新干预措施以改善患者护理和治疗结果。将创新治疗技术整合到吞咽困难的言语病理学治疗中,增强了传统策略,提供了可应用于不同年龄和种族群体的预后和治疗干预的最新知识。本综述还概述了症状学、评估技术以及与各种遗传性和后天性RDS相关的吞咽困难的具体特征。